FDA committee meets to debate and vote on Covid booster shots for the general public — 9/17/21 - YouTube
Pfizer asks FDA for approval to expand omicron booster to 5- to 11-year-olds | PBS NewsHour
FDA Panel Says Pfizer COVID Booster OK For Older People And Those At High Risk : Coronavirus Updates : NPR
New COVID vaccine: FDA signs off on updated 2023 COVID booster vaccines that target XBB.1.5 Omicron subvariant, EG.5 - ABC7 New York
FDA authorizes Pfizer COVID-19 vaccine boosters for people 65 and older, other at-risk groups - ABC News
FDA authorizes Pfizer's and Moderna's updated Covid booster shots
FDA staff say Pfizer COVID-19 boosters may not be needed, but do improve immunity | Reuters
FDA clears the way for additional bivalent boosters for certain vulnerable individuals | CNN
Pfizer asks FDA to authorize updated booster shot
CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News
FDA authorizes first COVID booster for children ages 5 to 11 - capradio.org
FDA approves another Covid booster for ages 50 and up; shot would be 4th vaccine dose - syracuse.com
Pfizer asks FDA to authorize Covid booster shots that target omicron BA.5 for people ages 12 and older
FDA advisory group recommends Moderna booster for emergency authorization
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
FDA recommends tweaked boosters target omicron subvariants
Tense decision-making as CDC joins FDA in recommending Pfizer booster shot for 65 & up, people at high risk and those with occupational exposure to COVID-19
FDA Says Young Kids Can Now Get Omicron Boosters Too | MedPage Today
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA
FDA panel endorses lower-dose Moderna COVID shot for booster | PBS NewsHour
FDA greenlights Pfizer booster shot for certain groups; CDC advisory panel votes to recommend boosters | AHA News
FDA and CDC authorize second COVID-19 booster - UT Physicians
FDA expected to recommend boosters for immunocompromised Americans within weeks: Source - ABC News
U.S. Health Officials Clear Second Booster for Those 50 and Older - The New York Times
FDA panel rejects broad use of COVID-19 boosters, approves extra doses for seniors, those at high risk | CBC News
FDA clears extra COVID booster for some high-risk, older Americans | PBS NewsHour
F.D.A. Advisers Recommend Updated Boosters Targeting Forms of Omicron - The New York Times
Biden's top-down booster plan sparks anger at FDA - POLITICO
